Medicus Pharma Ltd warrant (MDCXW) Market Cap (2024 - 2026)
Medicus Pharma Ltd warrant (MDCXW) market cap from Nov 14, 2024 to Jul 20, 2026. The current Medicus Pharma Ltd warrant (MDCXW) market cap is $16M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
Medicus Pharma Ltd warrant (MDCXW) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +130.49% |
Annual Market Cap change of Medicus Pharma Ltd warrant (MDCXW)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $16M | -22.55% |
| 2025 | $20M | +95.53% |
| 2024 | $10M | N/A |
Comparison Medicus Pharma Ltd warrant (MDCXW) market cap with competitors
Medicus Pharma Ltd warrant (MDCXW) market cap is $15.60M.
| Ticker | Name | Market Cap | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | $1.03T | +6630215.86% |
| JNJ | Johnson & Johnson | $594.97B | +3814262.05% |
| ABBV | Abbvie Inc | $432.22B | +2770831.60% |
| AZN | Astrazeneca plc | $295.54B | +1894628.56% |
| MRK | Merck & Co Inc | $291.57B | +1869141.67% |
| NVS | Novartis AG | $288.93B | +1852243.44% |
| NVO | Novo Nordisk | $224.93B | +1441898.64% |
| AMGN | AMGEN Inc | $193.39B | +1239690.01% |
| GILD | Gilead Sciences Inc | $163.57B | +1048553.56% |
| PFE | Pfizer Inc | $141.25B | +905455.40% |
| BMY | Bristol-Myers Squibb Company | $119.63B | +766849.81% |
| SNY | Sanofi | $105.20B | +674328.50% |
| GSK | GSK Plc | $104.78B | +671663.89% |
| BIIB | Biogen Inc | $29.03B | +186034.75% |
| GRFS | Grifols SA | $4.91B | +31358.36% |
| OGN | Organon & Company | $3.54B | +22614.98% |
| AMRN | Amarin Corp | $303.37M | +1844.88% |
| SCLX | Scilex Holding Company | $78.29M | +401.91% |
| MIRA | Mira Pharmaceuticals Inc | $39.50M | +153.27% |
| NSRX | Nasus Pharma Ltd | $28.10M | +80.17% |
| MDCX | MDCorp | $13.93M | -10.67% |